查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621606

囊泡转运蛋白检测市场：按类型、应用和最终用途划分 – 2025-2030 年全球预测

Vesicular Transporter Assay Market by Type (Colorimetric Assays, Fluorescence-Based Assays, Radioactive Assays), Application (Drug Development, Neurological Research, Toxicological Assessment), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年囊泡转运蛋白检测市值为6.0715亿美元，预计2024年将达到6.5967亿美元，复合年增长率为9.55%，到2030年将达到11.5014亿美元。

囊泡转运蛋白检测市场包括透过监测基材跨囊泡膜的转运来分析和测量转运蛋白活性，主要应用于药物开发和生物製药研究。这项市场需求是由于转运蛋白在理解介导的药物交互作用、毒性和药物动力学方面发挥关键作用，这使得它们在临床前药物筛检过程中至关重要。其应用范围涵盖製药业、生物医学研究和学术目的。我们确保，一系列最终用途包括製药公司、委外研发机构(CRO) 和学术研究机构，它们利用这些检测来加快药物发现过程并提高安全性和有效性。

主要市场统计
基准年[2023] 6.0715 亿美元
预计年份 [2024] 65967万美元
预测年份 [2030] 1,150,140,​​000 美元
复合年增长率（%） 9.55%

最近的市场成长是由慢性疾病日益流行所推动的，这需要新型疗法的市场开发并增加了对囊泡转运蛋白检测的需求。生物技术工具的进步和对个人化医疗日益增长的兴趣正在进一步推动这个市场。此外，在检测开发中采用人工智慧和机器学习为自动化和提高准确性提供了一个有希望的途径。然而，检测试剂套件的高成本、技术方法的复杂性以及严格的法规结构等限制带来了重大挑战。此外，缺乏训练有素的专业人员阻碍了最佳实施和可扩展性。

对于寻求发展的公司来说，扩大基因转运机制领域的研究以及开拓医疗基础设施快速发展的新兴经济体中尚未开发的市场存在潜在的机会。公司可以透过整合自动化技术和开发具有成本效益的高通量检测系统来简化流程并减少开销，从而实现创新。随着针对各种病理条件的转运蛋白的研究取得进展，我们将能够提供独特的产品。儘管监管环境充满挑战，但与监管机构的有效合作有助于建立更顺畅的打入市场策略。整体而言，囊泡转运蛋白检测市场的本质仍然是动态的，风险与机会并存，需要市场参与企业的敏捷性和持续创新。

市场动态：揭示快速发展的囊泡转运蛋白检测市场的关键市场洞察

供需的动态交互作用正在改变囊泡转运蛋白检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 神经系统疾病盛行率增加
    • 政府对神经药理学研究的投资
  • 市场限制因素
    • 囊泡转运蛋白检测缺乏报销
  • 市场机会
    • 核准后囊泡转运蛋白检测的进展
    • 囊泡转运蛋白检测在个人化医疗的应用
  • 市场挑战
    • 测定灵敏度和检测极限

波特五力：开拓囊泡转运蛋白检测市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对囊泡转运蛋白检测市场的外部影响

外部宏观环境因素在塑造囊泡转运蛋白检测市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解囊泡转运蛋白检测市场的竞争格局

对囊泡转运蛋白检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位基质囊泡转运蛋白检测市场供应商的绩效评估

FPNV定位矩阵是评估囊泡转运蛋白检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了囊泡转运蛋白检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对囊泡转运蛋白检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 神经系统疾病盛行率增加
      • 政府对神经药理学研究的投资
    • 抑制因素
      • 囊泡转运蛋白检测没有退款
    • 机会
      • 囊泡转运蛋白检测的核准取得进展
      • 囊泡转运蛋白检测在个人化医疗的应用
    • 任务
      • 测定灵敏度和检测极限
  • 市场区隔分析
    • 类型：放射性检测由于其精确定量的敏感性而越来越受到青睐
    • 应用：扩大囊泡转运蛋白检测在神经退化性疾病病理学的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章囊泡转运蛋白检测市场：按类型

  • 比色测定
  • 基于萤光的测定
  • 放射性分析

第七章囊泡转运蛋白检测市场：依应用分类

  • 药物开发
  • 神经学调查
  • 毒性评估

第八章囊泡转运蛋白检测市场：依最终用途

  • 学术研究所
  • 製药和生物技术公司

第 9 章：美洲囊泡转运蛋白检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区囊泡转运蛋白检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的囊泡转运蛋白检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Verichem 推出用于酵素法和比色法肌酸酐测量的标准材料
    • Eurofins Discovery 收购 Calixar 以扩大综合药物发现能力和专业知识
  • 战略分析和建议

公司名单

  • Abcam Limited
  • Advanced Cell Diagnostics, Inc.
  • Axxam SpA
  • BellBrook Labs
  • Bio-Rad Laboratories, Inc.
  • BioIVT LLC
  • Biosynth Ltd.
  • Cell4Pharma
  • CiteAb Limited
  • Discovery Life Sciences
  • Eagle Biosciences, Inc.
  • Eurofins Scientific SE
  • FyoniBio GmbH
  • Merck KGaA
  • Nanion Technologies
  • Pharmaron Beijing Co., Ltd.
  • PortaCellTec Biosciences GmbH
  • Revvity, Inc.
  • Sartorius AG
  • Siemens Healthineers AG
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-A413C23B642E

The Vesicular Transporter Assay Market was valued at USD 607.15 million in 2023, expected to reach USD 659.67 million in 2024, and is projected to grow at a CAGR of 9.55%, to USD 1,150.14 million by 2030.

The vesicular transporter assay market encompasses the analysis and measurement of transporter activity by monitoring the transport of substrates across vesicle membranes, primarily applicable in drug development and biopharmaceutical research. The necessity of this market arises from its critical role in understanding transporter-mediated drug-drug interactions, toxicity, and pharmacokinetics, which are essential in preclinical drug screening processes. Its applications extend to pharmaceutical industries, biomedical research, and academic purposes. The end-use scope includes pharmaceutical companies, contract research organizations (CROs), and academic research institutions, which utilize these assays to expedite the drug discovery process, ensuring safety and efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 607.15 million
Estimated Year [2024] USD 659.67 million
Forecast Year [2030] USD 1,150.14 million
CAGR (%) 9.55%

Recent market growth is driven by the increasing prevalence of chronic diseases, which necessitates the development of novel therapeutics, thereby elevating the demand for vesicular transporter assays. Advances in biotechnological tools and a growing focus on personalized medicine further propel this market. Additionally, the adoption of artificial intelligence and machine learning in assay development presents promising avenues for automation and increased precision. However, constraints such as high costs associated with assay kits, the complexity of technical methodologies, and stringent regulatory frameworks pose significant challenges. Moreover, a lack of trained professionals hinders optimum implementation and scalability.

For businesses aiming for growth, there exists a potential opportunity in expanding research in the areas of gene transporter mechanisms and exploring untapped markets in emerging economies, where healthcare infrastructures are rapidly developing. Companies can innovate by integrating automation technologies and developing cost-effective, high-throughput assay systems to streamline processes and reduce overheads. Further research on transporter proteins specific to diverse medical conditions can drive unique product offerings. Despite the challenging regulatory landscape, effective collaboration with regulatory entities can aid in establishing smoother market entry strategies. Overall, the nature of the vesicular transporter assay market remains dynamic, with a blend of risks and opportunities, demanding agility and continuous innovation from market participants.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vesicular Transporter Assay Market

The Vesicular Transporter Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of neurological disorders
    • Government investment in neuropharmacology research
  • Market Restraints
    • Lack of reimbursements for vesicular transporter assay
  • Market Opportunities
    • Advancements in vesicular transporter assay with approvals
    • Application of vesicular transporter assays for personalized medicine
  • Market Challenges
    • Sensitivity and detection limitations of the assays

Porter's Five Forces: A Strategic Tool for Navigating the Vesicular Transporter Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vesicular Transporter Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vesicular Transporter Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vesicular Transporter Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vesicular Transporter Assay Market

A detailed market share analysis in the Vesicular Transporter Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vesicular Transporter Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vesicular Transporter Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vesicular Transporter Assay Market

A strategic analysis of the Vesicular Transporter Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vesicular Transporter Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam Limited, Advanced Cell Diagnostics, Inc., Axxam S.p.A., BellBrook Labs, Bio-Rad Laboratories, Inc., BioIVT LLC, Biosynth Ltd., Cell4Pharma, CiteAb Limited, Discovery Life Sciences, Eagle Biosciences, Inc., Eurofins Scientific SE, FyoniBio GmbH, Merck KGaA, Nanion Technologies, Pharmaron Beijing Co., Ltd., PortaCellTec Biosciences GmbH, Revvity, Inc., Sartorius AG, Siemens Healthineers AG, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Vesicular Transporter Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Colorimetric Assays, Fluorescence-Based Assays, and Radioactive Assays.
  • Based on Application, market is studied across Drug Development, Neurological Research, and Toxicological Assessment.
  • Based on End-use, market is studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of neurological disorders
      • 5.1.1.2. Government investment in neuropharmacology research
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursements for vesicular transporter assay
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in vesicular transporter assay with approvals
      • 5.1.3.2. Application of vesicular transporter assays for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Sensitivity and detection limitations of the assays
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing preference for radioactive assays due to its sensitivity for precise quantification
    • 5.2.2. Application: Expanding application of vesicular transporter assay in pathophysiology of neurodegenerative diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vesicular Transporter Assay Market, by Type

  • 6.1. Introduction
  • 6.2. Colorimetric Assays
  • 6.3. Fluorescence-Based Assays
  • 6.4. Radioactive Assays

7. Vesicular Transporter Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Development
  • 7.3. Neurological Research
  • 7.4. Toxicological Assessment

8. Vesicular Transporter Assay Market, by End-use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Pharmaceutical & Biotechnology Companies

9. Americas Vesicular Transporter Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vesicular Transporter Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vesicular Transporter Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Verichem Launches Reference Materials for Enzymatic and Colorimetric Creatinine Assay
    • 12.3.2. Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam Limited
  • 2. Advanced Cell Diagnostics, Inc.
  • 3. Axxam S.p.A.
  • 4. BellBrook Labs
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BioIVT LLC
  • 7. Biosynth Ltd.
  • 8. Cell4Pharma
  • 9. CiteAb Limited
  • 10. Discovery Life Sciences
  • 11. Eagle Biosciences, Inc.
  • 12. Eurofins Scientific SE
  • 13. FyoniBio GmbH
  • 14. Merck KGaA
  • 15. Nanion Technologies
  • 16. Pharmaron Beijing Co., Ltd.
  • 17. PortaCellTec Biosciences GmbH
  • 18. Revvity, Inc.
  • 19. Sartorius AG
  • 20. Siemens Healthineers AG
  • 21. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. VESICULAR TRANSPORTER ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. VESICULAR TRANSPORTER ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VESICULAR TRANSPORTER ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VESICULAR TRANSPORTER ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VESICULAR TRANSPORTER ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VESICULAR TRANSPORTER ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY FLUORESCENCE-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY RADIOACTIVE ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY NEUROLOGICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TOXICOLOGICAL ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VESICULAR TRANSPORTER ASSAY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. VESICULAR TRANSPORTER ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. VESICULAR TRANSPORTER ASSAY MARKET, FPNV POSITIONING MATRIX, 2023